We are live on ! Find out more
CMPX icon

Compass Therapeutics
CMPX

38 hedge funds and large institutions have $104M invested in Compass Therapeutics in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 3

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

12% more funds holding

Funds holding: 34 → 38 (+4)

5.62% more ownership

Funds ownership: 61.11% → 66.73% (+5.6%)

2% less capital invested

Capital invested by funds: $106M → $104M (-$2.07M)

60% less funds holding in top 10

Funds holding in top 10: 5 → 2 (-3)

Holders
38
Holders Change
+4
Holders Change %
+11.76%
% of All Funds
0.65%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
9
Increased
11
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$10.2M
2
EAM
Eventide Asset Management
Massachusetts
+$3.05M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$2.43M
4
BlackRock
BlackRock
New York
+$1.96M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.6M

Top Sellers

1
CCM
Consonance Capital Management
New York
-$4.22M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.43M
3
CM
CM Management
Florida
-$80K
4
MWM
Mascoma Wealth Management
New Hampshire
-$42K
5
DCM
DAFNA Capital Management
California
-$27.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$16.1M +$10.2M +3,698,789 +111%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$14.5M -$1.43M -517,600 -8%
RSCM
3
Rock Springs Capital Management
Maryland
$12.2M +$14.1K +5,100 +0.1%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$10.5M +$554K +200,000 +5%
FCMV
5
Foresite Capital Management V
California
$10M – – –
CA
6
CHI Advisors
New York
$6.45M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$5.43M +$2.43M +878,650 +58%
APM
8
Avidity Partners Management
Texas
$4.56M – – –
VC
9
Vivo Capital
California
$4.56M – – –
FCOMV
10
Foresite Capital Opportunity Management V
California
$3.54M – – –
Blackstone Inc
11
Blackstone Inc
New York
$3.43M – – –
MIM
12
Monashee Investment Management
Massachusetts
$2.81M – – –
EAM
13
Eventide Asset Management
Massachusetts
$2.51M +$3.05M +1,100,399 New
BlackRock
14
BlackRock
New York
$1.99M +$1.96M +709,071 +434%
FAM
15
Fred Alger Management
New York
$1.39M – – –
Geode Capital Management
16
Geode Capital Management
Massachusetts
$1.37M +$1.6M +576,467 +2,319%
SCM
17
Silverarc Capital Management
Massachusetts
$598K +$726K +262,090 New
DCM
18
DAFNA Capital Management
California
$429K -$27.7K -10,000 -5%
LP
19
LMR Partners
United Kingdom
$228K – – –
Northern Trust
20
Northern Trust
Illinois
$199K +$242K +87,367 New
Renaissance Technologies
21
Renaissance Technologies
New York
$146K -$5.4K -1,950 -3%
Millennium Management
22
Millennium Management
New York
$144K +$97.8K +35,326 +127%
Marshall Wace
23
Marshall Wace
United Kingdom
$117K +$77.8K +28,089 +118%
Charles Schwab
24
Charles Schwab
California
$73K +$87.9K +31,736 New
SIC
25
Salem Investment Counselors
North Carolina
$68K – – –
1
2

CMPX Hedge Fund Activity: Q3 2022 in Review

38 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Compass Therapeutics (CMPX) for Q3 2022, worth a combined $104M — down 2% from $106M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CMPX positions and 4 closed out — a net gain of 5 holders — while 11 added to existing stakes and 3 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $10.2M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $4.22M sold.

  • 38 institutional investors held Compass Therapeutics (CMPX) as of Q3 2022, up from 34 in Q2 2022.
  • Funds reported $104M of Compass Therapeutics stock for Q3 2022, down 2% quarter-over-quarter.
  • 9 funds opened new Compass Therapeutics positions in Q3 2022 and 4 closed out, a net change of +5 holders.
  • The largest Compass Therapeutics buyer in Q3 2022 was Janus Henderson Group, an estimated $10.2M added.
  • The largest Compass Therapeutics seller in Q3 2022 was Consonance Capital Management, an estimated $4.22M sold.

Based on aggregated 13F filings for Q3 2022.